Table 4.
Angiographic, clinical, and biochemical properties of patients in death and survived groups.
| Death, n = 14 | Survived, n = 54 | p value | |
|---|---|---|---|
| Female sex, n (%) | 5 (35.7) | 7 (13) | 0.06 |
| Age, years | 73.36 ± 10.59 | 58.44 ± 14.14 | <0.001 |
| DM, n (%) | 2 (14.3) | 10 (18.5) | 0.53 |
| HT, n (%) | 9 (64.3) | 20 (37) | 0.06 |
| DL, n (%) | 1 (7.1) | 7 (%13) | 0.47 |
| Smoking, n (%) | 9 (64.3) | 42 (77.8) | 0.23 |
| Family history of CAD, n (%) | 0 (0) | 9 (16.7) | 0.12 |
| Admission time (hours) | 6.35 ± 2.87 | 4.15 ± 2.84 | 0.01 |
| Admission SBP (mmHg) | 103.57 ± 27.90 | 117.87 ± 20.27 | 0.03 |
| Myocardial infarction localization | |||
| Anterior wall MI, n (%) | 9 (64.3) | 16 (29.6) | 0.04 |
| Inferior wall MI, n (%) | 3 (21.4) | 30 (55.6) | |
| Posterolateral wall MI, n (%) | 2 (14.3) | 8 (14.8) | |
| Primer PCI, n (%) | 8 (57.1) | 32 (59.3) | 0.56 |
| Fibrinolytic administration, n (%) | 8 (40.7) | 22 (57.1) | 0.21 |
| NGAL (ng/ml) | 357 (71–694) | 120 (9–513) | <0.001 |
| Troponin I (ng/ml) | 7.39 (0.30–25.00) | 1.05 (0.1–25.00) | 0.15 |
| CKMB (ng/ml) | 20.49 (3.05–300.00) | 12.33 (1.63–380.00) | 0.21 |
| CRP (mg/dl) | 0.71 (0,05–7.06) | 0.52 (0.09–9.59) | 0.83 |
| Creatinine (mg/dl) | 1.01 ± 0.21 | 0.85 ± 0.17 | 0.007 |
| GFR (ml/min) | 78.35 ± 22.53 | 107.46 ± 19.58 | <0.001 |
| LDL (mg/dl) | 119.25 ± 28.11 | 125.67 ± 36.32 | 0.54 |
| HDL (mg/dl) | 38.92 ± 10.30 | 36.06 ± 8.70 | 0.29 |
| Haemoglobin (mg/dl) | 13.70 ± 2.34 | 15.08 ± 2.19 | 0.06 |
| Leukocytes (K/uL) | 13.06 ± 4.57 | 12.09 ± 4.45 | 0.49 |
| Platelets (K/uL) | 262 (80–428) | 239 (72–485) | 0.66 |
| Neutrophils (K/uL) | 10.15 ± 4.20 | 8.73 ± 4.03 | 0.27 |
| Lymphocytes (K/uL) | 1.97 ± 0.82 | 2.26 ± 1.48 | 0.50 |
| Neutrophil-to-lymphocyte ratio | 5.08 (2.04–10.74) | 4.44 (0.56–19.90) | 0.38 |
Significant p values are in bold. CAD, coronary artery disease; CKMB, creatine kinase MB; CRP, C-reactive protein; DL, dyslipidemia; DM, diabetes mellitus; GFR, glomerular filtration rate; HDL, high-density lipoprotein; HT, hypertension; LDL, low-density lipoprotein; MI, myocardial infarction; NGAL, neutrophil gelatinase-associated lipocalin; PCI, percutaneous coronary intervention; SBP, systolic blood pressure.